GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 [Yahoo! Finance]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Yahoo! Finance
by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 taking place in San Diego, California from April 17-22. The company will also participate in the Myriad Genetics Spotlight Theater (“Advances in ctDNA Testing towards Biopharma Development & Clinical Dx”) and Discovery Life Sciences Flash Talk during the meeting. “Our 2026 AACR presentations will showcase the significant progress we've made in advancing our ExpressCT™ liquid biopsy technology,” said Michael Milburn, PhD, President and Chief Executive Officer of GeneCentric. “Along with our collaborators, we look forward to presenting new data highlighting how ExpressCT is not tied to a single assay format but is compatible with whole genome sequencing, established gene panels, and our custom-designed GenomicsNext™ hybrid-capture panel. Our data show that fragmentomics can provide prognostic insight, detect
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026GlobeNewswire
- Myriad Genetics (MYGN) was upgraded by TD Cowen to "hold".MarketBeat
- Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in JapanGlobeNewswire
- Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual MeetingGlobeNewswire
MYGN
Earnings
- 2/23/26 - Beat
MYGN
Sec Filings
- 4/15/26 - Form 4
- 4/15/26 - Form 4
- 4/14/26 - Form ARS
- MYGN's page on the SEC website